Aortic Stent Grafts Market

Industry Outlook

The aortic stent graft market was worth US$ 1,605.3 million in 2017 and was expected to grow at an 8.1% CAGR from 2018 to 2026. Aortic stent grafts are used in aneurysms, which are caused by abnormally dilated arteries. The aortic stent grafts are implanted using specialized catheters inserted through minor surgical incisions in the groin. Aortic stent grafts are threaded through the abdominal aorta, guided by an x-ray. Thus, being a minimally invasive surgery, aortic stent grafts are the most preferred grafts by medical practitioners in aneurysm treatment. On June 12, 2018, the FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee voted 11-4, confirming that the advantages of aortic stent grafts designed for the endovascular treatment of infrarenal abdominal aortic aneurysms overshadow the potential risks possessed by this device. The major key market drivers for the market are the increasing prevalence of aneurysms coupled with a geriatric population, incessant technological advancements in minimally invasive procedure techniques, and unmet needs related to healthcare and disease awareness in developing and underdeveloped countries globally.

Market Synopsis

Abdominal aortic stent grafts are the largest market due to the increasing prevalence of abdominal aortic aneurysms (AAA).

In 2017, abdominal aortic stent grafts were expected to be the largest segment due to key market drivers such as increasing adoption of minimally invasive surgeries over open surgeries, continuous development in the technology of aortic stent grafts, and long-term clinical data collected in the near future that will increase abdominal aortic stent graft demand. In 2016, abdominal aortic aneurysm-specific complications were responsible for 9758 deaths in the United States, with an estimated rate of 3.0 deaths per 100,000. According to the Centers for Disease Control (CDC), AAA ranks as one of the top 15 causes of death in the United States, specifically seen in people over the age of 80.

The growing number of hospitals, combined with the increasing penetration of modern surgical devices, is expected to drive the aortic stent graft market forward.

The hospital’s segment accounted for the largest market share in 2017 and will maintain its dominance throughout the forecast period from 2018 to 2026. The demand for skilled professionals is increasing in hospitals and is expected to exhibit exponential growth in the near future with the rapid increase in the number of hospitals in developing countries. Supportive reimbursement policies for aortic stent grafts have also assisted the growth of the aortic stent graft market and its penetration in the market. According to a research study published in Healthcare Asia, in 2015, there were approximately 53,535 hospitals in Asia, compared to 33,883 in 2008; this signifies the demand growth for hospitals in Asia, specifically in developing and underdeveloped countries. However, ambulatory care centers are growing significantly in developed and a few developing countries due to the increasing demand for cost-effective, minimally invasive, and time-saving aortic aneurysm treatment surgeries.

The rising prevalence of aneurysms and awareness related to early disease diagnosis is assisting the growth of the aortic stent graft market in the Asia Pacific.

During the forecast period of 2018 to 2026, Asia Pacific was identified as the fastest-growing aortic stent graft market. The key drivers responsible for its growth are the increasing prevalence of aortic aneurysms, rising public awareness related to early disease diagnosis, and an increasing number of healthcare facilities due to the spurt in the economic growth of this region. North America is expected to maintain its dominance throughout the forecast period due to the presence of organized and supportive reimbursement policies, the increasing prevalence of aortic aneurysms, and the high demand for minimally invasive surgeries.

Periods of History and Forecast

The aortic stent grafts market was analyzed considering current market trends for the base year of 2017, and based on future trends, CAGRs were calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on the aortic stent graft market covers exhaustive qualitative and quantitative data related to the major market dynamics, such as drivers, opportunities, and restraints, along with regional and country-specific market trends. An exhaustive summary of the global aortic stent graft market is provided in the report by segmenting the market based on product type and geography. The objective of publishing this in-depth research report is to assist industry stakeholders in carrying out decisions and strategy implementation in the aortic stent graft market.

This report further describes the major qualitative assessment factors, including key market trends, market drivers, opportunities, and restraints, to gain a precise understanding of the global aortic stent graft market. Moreover, the major players operating in the market are analyzed based on several attributes, such as product portfolio, business strength, and key market strategies. The report also provides an attractive investment proposition based on the extensive geographical research carried out based on PESTEL analysis. Key players profiled in the report include Medtronic Plc, Cardinal Health, Inc., Cook Medical Inc., W.L. Gore & Associates Inc., Terumo Corporation Inc., ENDOLOGIX, INC., Lombard Medical, Inc., CryoLife, Inc., MicroPort Scientific Corporation, Altura Medical, and Aptus Endosystems, among others.

Key questions are answered in this report.

• Which is the most in-demand aortic stent graft type on the market, and why?
• What are the recent market strategies practiced by key players operating in the aortic stent graft market?
• Which are the most attractive regions and countries dominating and rapidly growing in the aortic stent graft market?
• Which is the largest and fastest-growing aortic stent graft type globally?
• What are the competitive landscape of the aortic stent graft market and the strategies of key players operating in this industry?

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global ASG Market Portraiture
2.2. Global ASG Market, By Product, 2017 (US$ Mn)
2.3. Global ASG Market, By End-User, 2017 (US$ Mn)
2.4. Global ASG Market, by Geography, 2017 Vs 2026 (Value %)

Chapter 3. Global Aortic Stent Grafts (ASG) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Challenges
3.3. Opportunities
3.4. Attractive Investment Proposition, by Geography, 2017
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Aortic Stent Grafts (ASG) Market, by Product, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Abdominal Aortic Stent Graft
4.3. Thoracic Aortic Stent Graft

Chapter 5. Global Aortic Stent Grafts (ASG) Market, by End-User, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Hospitals
5.3. Ambulatory Care Centers

Chapter 6. Global Aortic Stent Grafts (ASG) Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. North America ASG Market Analysis, 2016 – 2026
6.2.1. North America ASG Market, By Product, 2016 – 2026 (US$ Mn)
6.2.2. North America ASG Market, By End-User, 2016 – 2026 (US$ Mn)
6.2.3. North America ASG Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe ASG Market Analysis, 2016 – 2026
6.3.1. Europe ASG Market, By Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe ASG Market, By End-User, 2016 – 2026 (US$ Mn)
6.3.3. Europe ASG Market, by Country, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific ASG Market Analysis, 2016 – 2026
6.4.1. Asia Pacific ASG Market, By Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific ASG Market, By End-User, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific ASG Market, by Country, 2016 – 2026 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America ASG Market Analysis, 2016 – 2026
6.5.1. Latin America ASG Market, By Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America ASG Market, By End-User, 2016 – 2026 (US$ Mn)
6.5.3. Latin America ASG Market, by Country, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) ASG Market Analysis, 2016 – 2026
6.6.1. MEA ASG Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA ASG Market, by End-User, 2016 – 2026 (US$ Mn)
6.6.3. MEA ASG Market, by Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Medtronic Plc
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Cardinal Health, Inc.
7.3. Terumo Corporation Inc.
7.4. Becton, Dickinson and Company
7.5. CryoLife, Inc.
7.6. ENDOLOGIX, INC.
7.7. Cook Medical Inc.
7.8. Lombard Medical, Inc.
7.9. W.L. Gore & Associates Inc.
7.10. MicroPort Scientific Corporation
7.11. Altura Medical
7.12. Aptus Endosystems

List of Figures

FIG. 1 Aortic Stent Grafts (ASG) Market Segmentation
FIG. 2 Global ASG Market Share, By Product, 2017 (US$ Mn)
FIG. 3 Global ASG Market Share, By End-Users, 2017 (US$ Mn)
FIG. 4 Global ASG Market, by Geography, 2017 Vs 2026 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2017
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Abdominal ASG Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Thoracic ASG Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global ASG Market in Hospitals, 2016 – 2026 (US$ Mn)
FIG. 10 Global ASG Market in Ambulatory Care Centers, 2016 – 2026 (US$ Mn)
FIG. 11 U.S. ASG Market, 2016 – 2026 (US$ Mn)
FIG. 12 Canada ASG Market, 2016 – 2026 (US$ Mn)
FIG. 13 U.K. ASG Market, 2016 – 2026 (US$ Mn)
FIG. 14 Germany ASG Market, 2016 – 2026 (US$ Mn)
FIG. 15 Rest Of Europe ASG Market, 2016 – 2026 (US$ Mn)
FIG. 16 Japan ASG Market, 2016 – 2026 (US$ Mn)
FIG. 17 China ASG Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest Of Asia Pacific ASG Market, 2016 – 2026 (US$ Mn)
FIG. 19 Brazil ASG Market, 2016 – 2026 (US$ Mn)
FIG. 20 Mexico ASG Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest Of Latin America ASG Market, 2016 – 2026 (US$ Mn)
FIG. 22 GCC ASG Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest Of Middle East And Africa ASG Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Aortic Stent Grafts (ASG) Market, By Product, 2016 – 2026 (US$ Mn)
TABLE 2 Global ASG Market, By End-User, 2016 – 2026 (US$ Mn)
TABLE 3 North America ASG Market, By Product, 2016 – 2026 (US$ Mn)
TABLE 4 North America ASG Market, By End-User, 2016 – 2026 (US$ Mn)
TABLE 5 North America ASG Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 6 Europe ASG Market, By Product, 2016 – 2026 (US$ Mn)
TABLE 7 Europe ASG Market, By End-User, 2016 – 2026 (US$ Mn)
TABLE 8 Europe ASG Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific ASG Market, By Product, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific ASG Market, By End-User, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific ASG Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America ASG Market, By Product, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America ASG Market, By End-User, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America ASG Market, By Country/Region, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East And Africa ASG Market, By Product, 2016 – 2026 (US$ Mn)
TABLE 16 Middle East & Africa ASG Market, By End-User, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East And Africa ASG Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 18 Medtronic Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Cardinal Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Terumo Corporation Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 ENDOLOGIX, INC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Cook Medical Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Lombard Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 W.L. Gore & Associates Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 MicroPort Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Altura Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Aptus Endosystems: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)